Tue, 16 May 2017 12:00:00 +0200 Sanofi.com : Investors Latest available publications - New events and presentations - Latest regulation information in France http://en.sanofi.com/investors/events/calendar/calendar.aspx Tue, 16 May 2017 12:00:00 +0200 Shareholder Handbook 2017

The Shareholder handbook gives an overview of Sanofi in facts and figures, and provides information about how to manage your shareholdings and about our relationship with our shareholders.

http://en.sanofi.com/investors/indiv_shareholders/publications/handbook/handbook.aspx
Wed, 10 May 2017 14:30:00 +0200 Shareholders’ General Meeting, Paris, France

The Sanofi General Meeting will be held on May 10, 2017 at the Palais des Congrès in Paris, France.

http://en.sanofi.com/investors/events/general_meetings/2017_meeting/2017_meeting.aspx
Thu, 04 May 2017 15:30:00 +0200 42nd Annual Deutsche Bank Health Care Conference, Boston, U.S.

Presentation by Jérôme Contamine, Executive Vice President, Chief Financial Officer

http://en.sanofi.com/investors/events/other_events/2017/2017.aspx
Fri, 28 Apr 2017 07:30:00 +0200 Q1 2017 Results

Q1 2017 Results will be reviewed on April 28, 2017 at 2:30 pm CEST/8:30 am EDT during a conference call.

http://en.sanofi.com/investors/events/Results/2017-04-28_Results_Q1_2017.aspx
Tue, 28 Mar 2017 09:00:00 +0200 Letter to Shareholders - March 2017

This new issue focuses on fourth-quarter and full year 2016 results, the launch of SoliquaTM, the KevzaraTM approval in Canada, the Sanofi Consumer Healthcare global business unit (GBU) and the digitalization of the Letter to shareholders.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Tue, 28 Mar 2017 13:00:00 +0200 IR thematic call on Dupixent®

Sanofi and Regeneron will host a conference call & webcast following the approval of Dupixent® for the treatment of adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD), a serious, chronic inflammatory skin disease.

http://en.sanofi.com/investors/events/corporate/2017-03-29_IR_Call_dupilumab.aspx
Fri, 04 Mar 2016 15:00:00 +0100 Publication of the Annual Report on Form 20-F 2016 and Document de Référence 2016 http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx Thu, 16 Feb 2017 15:30:00 +0100 Leerink Global Healthcare Conference, New York, U.S.

Presentation by David Meeker, Executive Vice President and General Manager of Sanofi Genzyme

http://en.sanofi.com/investors/events/other_events/2017/2017.aspx
Wed, 08 Feb 2017 07:30:00 +0100 Q4 and Full Year 2016 Results

Q4 and Full Year 2016 Results will be reviewed on February 8, 2017 at 2:00 pm (CET) during a conference call.

http://en.sanofi.com/investors/events/Results/2017-02-08_Results_FY_2016.aspx
Fri, 16 Dec 2016 09:00:00 +0100 Letter to Shareholders - December 2016

This new issue focuses on third-quarter 2016 results, Dupixent®, our investigational treatment for atopic dermatitis, Sanofi Genzyme, the fast-growing Speciality Care business unit and the Salon Actionaria 2016.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Fri, 28 Oct 2016 07:30:00 +0200 Third quarter results 2016

Third quarter results for 2016 will be reviewed by management during a conference call with the financial community on October 28, 2016 at 2:30 pm CET / 8:30 am EDT.

http://en.sanofi.com/investors/events/Results/2016-10-28_Results_Q3_2016.aspx
Sat, 01 Oct 2016 13:00:00 +0200 IR thematic call on dupilumab - EADV 2016

Sanofi and Regeneron will host a conference call at the European Academy of Dermatology and Venereology Congress on October 1, 2016 at 1:00 pm CET / 7:00 am EDT.

http://en.sanofi.com/investors/events/corporate/2016/2016-10-01_IR_Call_dupilumab.aspx
Thu, 29 Sep 2016 18:00:00 +0200 Individual shareholder meeting in Nice, France

Presentation held at the individual shareholder meeting in Nice (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2016_events/2016_shareholder_meetings/2016_shareholder_meetings.aspx
Mon, 26 Sep 2016 10:00:00 +0200 Letter to Shareholders - September 2016

This new issue focuses on second-quarter 2016 results, definitive agreements between Sanofi and Boehringer Ingelheim for business swap, recent approvals and progress in R&D and the Individual Shareholders Committee.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Thu, 22 Sep 2016 10:00:00 +0200 Bernstein Strategic Decisions Conference, London, UK

Audio webcast of the presentation by Jérôme Contamine, Executive Vice President, Chief Financial Officer

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Fri, 16 Sep 2016 11:40:00 +0200 Bank of America Merrill Lynch Global Healthcare Conference, London, UK

Audio webcast of the presentation by Olivier Brandicourt, Chief Executive Officer

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Mon, 12 Sep 2016 18:30:00 +0200 Individual shareholder meeting in Bordeaux, France

Presentation held at the individual shareholder meeting in Bordeaux (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2016_events/2016_shareholder_meetings/2016_shareholder_meetings.aspx
Mon, 12 Sep 2016 17:05:00 +0200 Morgan Stanley Global Healthcare Conference 2016, New York, U.S.

Audio webcast of the fireside chat with Elias Zerhouni, President, Global R&D

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Fri, 29 Jul 2016 15:00:00 +0200 Publication of the Half-year financial report 2016

Sanofi announces that its half-year financial report for 2016 is now available online.

http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx
Fri, 29 Jul 2016 07:30:00 +0200 Second quarter results 2016

Second quarter results for 2016 will be reviewed by management during a conference call with the financial community on July 29, 2016 at 2:30 pm CET (8:30 am ET).

http://en.sanofi.com/investors/events/Results/2016-07-29_Results_Q2_2016.aspx
Mon, 27 Jun 2016 18:00:00 +0200 Individual shareholder meeting in Biarritz, France

Presentation held at the individual shareholder meeting in Biarritz (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2016_events/2016_shareholder_meetings/2016_shareholder_meetings.aspx
Mon, 27 Jun 2016 14:30:00 +0200 IR Conference Call following the signing of contracts with Boehringer Ingelheim

Sanofi will host a conference call following the signing of contracts with Boehringer Ingelheim to swap Sanofi’s Animal Health and Boehringer Ingelheim’s Consumer Healthcare businesses at 2:30 pm CET / 8:30 am ET.

http://en.sanofi.com/investors/events/corporate/2016/2016-06-27_IR_Call.aspx
Fri, 17 Jun 2016 10:00:00 +0200 Letter to Shareholders - June 2016

This new issue focuses on first-quarter 2016 results, the first public dengue immunization program, recent partnerships and advances in R&D, the general meeting 2016 and changes in the executive committee.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Tue, 07 Jun 2016 16:45:00 +0200 Goldman Sachs Annual Global Healthcare Conference, Palos Verdes, U.S.

Discussion with Elias Zerhouni, President, Global R&D

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Tue, 24 May 2016 18:00:00 +0200 Individual shareholder meeting in Aix-en-Provence, France

Presentation held at the individual shareholder meeting in Aix-en-Provence (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2016_events/2016_shareholder_meetings/2016_shareholder_meetings.aspx
Wed, 04 May 2016 14:30:00 +0200 Shareholders’ General Meeting, Paris, France

The Sanofi General Meeting will be held on May 4, 2016 at the Palais des Congrès in Paris, France.

http://en.sanofi.com/investors/events/general_meetings/2016_meeting/2016_meeting.aspx
Wed, 04 May 2016 14:00:00 +0200 Shareholder Handbook 2016

The Shareholder handbook gives an overview of Sanofi in facts and figures, and provides information about how to manage your shareholdings and about our relationship with our shareholders.

http://en.sanofi.com/investors/indiv_shareholders/publications/handbook/handbook.aspx
Tue, 08 Mar 2016 16:45:00 +0100 Cowen Annual Healthcare Conference, Boston, U.S.

Presentation by Elias Zerhouni, President, Global R&D

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Fri, 29 Apr 2016 07:30:00 +0200 First quarter results 2016

First quarter results for 2016 will be reviewed by management during a conference call with the financial community on April 29, 2016 at 2:30 pm CET (8:30 am EST).

http://en.sanofi.com/investors/events/Results/2016-04-29_Results_Q1_2016.aspx
Wed, 23 Mar 2016 10:00:00 +0100 Letter to Shareholders - March 2016

This new issue of the Letter focuses on solid annual results 2015, the exclusive negotiations with Boehringer Ingelheim on a possible business swap, new partnerships in oncology, the launch of Dengvaxia®, world's first vaccine against dengue and the agenda of the upcoming general meeting.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Fri, 04 Mar 2016 15:00:00 +0100 Publication of the Annual Report on Form 20-F 2015 and Document de Référence 2015 http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx Thu, 11 Feb 2016 16:45:00 +0100 Leerink Global Healthcare Conference, New York, U.S.

Presentation by David Meeker, Executive Vice President, Head of Sanofi Genzyme

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Tue, 09 Feb 2016 07:30:00 +0100 Annual Results 2015

Annual Results 2015 will be reviewed on February 9, 2016 at 2:30 pm (CET) during a conference call.

http://en.sanofi.com/investors/events/Results/2016-02-09_Results_2015.aspx
Tue, 12 Jan 2016 18:30:00 +0100 34th Annual JP Morgan Healthcare Conference, San Francisco, U.S.

Webcast of the presentation by Olivier Brandicourt, CEO

http://en.sanofi.com/investors/events/other_events/2016/2016.aspx
Thu, 18 Jun 2015 10:00:00 +0200 Letter to Shareholders - December 2015

This new issue of the Letter focuses on third quarter results 2015, new collaborations in diabetes and the strategic roadmap for 2015-2020.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Mon, 09 Nov 2015 21:30:00 +0100 Sanofi & Regeneron Conference Call on sarilumab

At 4:00 pm CET (10:00 am EST) Sanofi and Regeneron will host an IR conference call for the financial community on sarilumab.

http://en.sanofi.com/investors/events/corporate/2015/2015-11-09_IR_Call_sarilumab.aspx
Fri, 06 Nov 2015 07:30:00 +0100 Meet Sanofi Management

Sanofi organized a "Meet Sanofi Management" Seminar in Paris. Senior management representatives provided a business update and outlined a roadmap towards 2020. We also presented the latest progress of our R&D pipeline.

http://en.sanofi.com/investors/events/corporate/2015/2015-11-06_IR_Seminar_Meet_Management.aspx
Thu, 29 Oct 2015 07:30:00 +0100 Third quarter results 2015

Third quarter results for 2015 will be reviewed by management during a conference call with the financial community on October 29, 2015 at 2:30 pm CET (9:30 am EDT).

http://en.sanofi.com/investors/events/corporate/2015/2015-10-29_Results_Q3_2015.aspx
Mon, 05 Oct 2015 18:00:00 +0200 Individual shareholder meeting in Lyon, France

Presentation held at the individual shareholder meeting in Lyon (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2015_events/2015_shareholder_meetings/2015_shareholder_meetings.aspx
Tue, 29 Sep 2015 18:00:00 +0200 Individual shareholder meeting in Lille, France

Presentation held at the individual shareholder meeting in Lille (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2015_events/2015_shareholder_meetings/2015_shareholder_meetings.aspx
Tue, 22 Sep 2015 10:00:00 +0200 Letter to Shareholders - September 2015

This new issue of the Letter focuses on second quarter results 2015, the approval of Praluent® in the U.S, the announcement of the group's new structure and new parterships in immuno-oncology.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Fri, 31 Jul 2015 15:00:00 +0200 Publication of the Half-year financial report 2015

Sanofi announces that its half-year financial report for 2015 is now available online.

http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx
Thu, 30 Jul 2015 07:30:00 +0200 Second quarter results 2015

Second quarter results for 2015 will be reviewed by management during a conference call with the financial community on July 30, 2015 at 2:30 pm CET (8:30 am EDT).

http://en.sanofi.com/investors/events/corporate/2015/2015-07-30_Results_Q2_2015.aspx
Fri, 24 Jul 2015 21:30:00 +0200 Sanofi & Regeneron Conference Call on the Praluent® U.S. FDA Approval

At 9:30 pm CET (3:30 pm EDT) Sanofi and Regeneron will host an IR conference call for the financial community on the FDA approval of Praluent®.

http://en.sanofi.com/investors/events/corporate/2015/2015-07-24_Praluent_call.aspx
Thu, 18 Jun 2015 10:00:00 +0200 Letter to Shareholders - June 2015

This new issue of the Letter focuses on first quarter results 2015, the approval of Toujeo® in Europe and in the U.S, further progress in R&D and the annual general meeting 2015.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Tue, 09 Jun 2015 14:30:00 +0200 IR Thematic Conference Call on Diabetes

At 2:00 pm CEST (8:00 am EDT) Sanofi hosted an IR Thematic Conference Call for the financial community in connection with the American Diabetes Association's Scientific Sessions.

http://en.sanofi.com/investors/events/corporate/2015/2015-06-09_IR_Seminar_Diabetes.aspx
Thu, 28 May 2015 18:00:00 +0200 Individual shareholder meeting in Nice, France

Presentation held at the individual shareholder meeting in Nice (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2015_events/2015_shareholder_meetings/2015_shareholder_meetings.aspx
Mon, 04 May 2015 14:00:00 +0200 Shareholder Handbook 2015 edition http://en.sanofi.com/investors/indiv_shareholders/publications/handbook/handbook.aspx Tue, 19 May 2015 14:30:00 +0200 Berenberg European Conference, Tarrytown, U.S.

Presentation by Elias Zerhouni, President, Global R&D

http://en.sanofi.com/investors/events/other_events/2015/2015.aspx
Wed, 06 May 2015 15:15:00 +0200 Deustche Bank Healthcare Conference, Boston, U.S.

Presentation by Jérôme Contamine, Executive Vice President & Chief Financial Officer

http://en.sanofi.com/investors/events/other_events/2015/2015.aspx
Mon, 04 May 2015 14:30:00 +0200 Shareholders’ General Meeting, Paris, France

The Sanofi General Meeting will be held on May 4, 2015 at the Palais des Congrès in Paris, France.

http://en.sanofi.com/investors/events/general_meetings/2015_meeting/2015_meeting.aspx
Thu, 30 Apr 2015 07:30:00 +0200 First quarter results 2015

First quarter results for 2015 will be reviewed by management during a conference call with the financial community.

http://en.sanofi.com/investors/events/corporate/2015/2015-04-30_Results_Q1_2015.aspx
Wed, 18 Mar 2015 15:15:00 +0100 Exane BNP Paribas Healthcare Conference, Paris, France

Presentation by Jérôme Contamine, Executive Vice President & Chief Financial Officer

http://en.sanofi.com/investors/events/other_events/2015/2015.aspx
Mon, 16 Mar 2015 10:00:00 +0100 Letter to Shareholders - March 2015

This new issue of the Letter focuses on annual results 2014, the nomination of Olivier Brandicourt as CEO, the approval of Afrezza® in the U.S., Genzyme's comitment to Gaucher disease patients and the annual general meeting 2015.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Wed, 11 Mar 2015 12:00:00 +0100 Publication of the Annual Report on Form 20-F 2014 and Document de Référence 2014 http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx Tue, 10 Mar 2015 15:15:00 +0100 Barclays Global Healthcare Conference, Miami, U.S.

Presentation by Paul Chew, Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs

http://en.sanofi.com/investors/events/other_events/2015/2015.aspx
Wed, 04 Mar 2015 18:30:00 +0100 Cowen Annual Healthcare Conference, Boston, U.S.

Presentation by Elias Zerhouni, President, Global R&D

http://en.sanofi.com/investors/events/other_events/2015/2015.aspx
Thu, 05 Feb 2015 18:30:00 +0100 Annual Results 2014

Annual Results 2014 will be presented on February 5, 2015 at 2:30 p.m (CET) during an audio webcast.

http://en.sanofi.com/investors/events/corporate/2015/2015-02-05_Results_2014.aspx
Mon, 12 Jan 2015 18:30:00 +0100 33rd Annual JP Morgan Healthcare Conference, San Francisco, U.S.

Webcast of the presentation by Elias Zerhouni, President, Global R&D

http://en.sanofi.com/investors/events/other_events/2015/2015.aspx
Mon, 05 Jan 2015 10:00:00 +0100 Letter to Shareholders - December 2014

This new issue of the Letter focuses on Q3 2014 results, the IR Thematic seminar on New Medicines - the approval of Lemtrada® in the U.S. and the launch of new Phase III studies.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Thu, 20 Nov 2014 07:30:00 +0100 IR Thematic Seminar on New Medicines

Sanofi will hold an IR Thematic Seminar on New Medicines in Cambridge, MA. A live video webcast will be available at 2:30 pm CET / 1:30 pm GMT / 8:30 am EST.

http://en.sanofi.com/investors/events/corporate/2014/2014-11-20_IR_Seminar_NMD.aspx
Wed, 29 Oct 2014 14:30:00 +0100 Conference Call with Serge Weinberg for the Financial Community

Sanofi hosted a conference call with Serge Weinberg for the financial community.

http://en.sanofi.com/investors/events/corporate/2014/2014-10-29_IR_Call_Weinberg.aspx
Tue, 28 Oct 2014 07:30:00 +0100 Third quarter results 2014

Third quarter results for 2014 will be reviewed by management during a conference call with the financial community.

http://en.sanofi.com/investors/events/corporate/2014/2014-10-28_Results_Q3-2014.aspx
Thu, 25 Sep 2014 10:00:00 +0200 Letter to Shareholders - September 2014

This new issue of the Letter focuses on Q2 2014 results, our dengue vaccine candidate, Alirocumab - a biological molecule targeting a new pathway for cholesterol management and the Tours production site visit by our shareholder committee.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Thu, 18 Sep 2014 12:00:00 +0200 Bank of America Merrill Lynch Healthcare Conference, London, UK

Presentation by Jérôme Contamine, Executive VP & Chief Financial Officer

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Wed, 17 Sep 2014 18:00:00 +0200 CLSA Investors Forum, Hong Kong, China

Presentation by Jean-Marie Arnaud, Vice President, Southeast Asia and Indochina, Global Operations

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Wed, 17 Sep 2014 12:00:00 +0200 Bernstein Strategic Decisions Conference, London, UK

Chat with Peter Guenter, Executive Vice President, Global Commercial Operations

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Tue, 16 Sep 2014 18:00:00 +0200 Individual shareholder meeting in Nice, France

Presentation held at the individual shareholder meeting in Nice (in French)

http://en.sanofi.com/investors/indiv_shareholders/events/2014_events/2014_shareholder_meetings/2014_shareholder_meetings.aspx
Mon, 08 Sep 2014 16:00:00 +0200 J.P. Morgan CEO Conference Call

Conference call with Christopher Viehbacher, Chief Executive Officer.

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Mon, 08 Sep 2014 16:00:00 +0200 Morgan Stanley Global Healthcare Conference, New York, U.S.

Chat with Elias Zerhouni, President, Global R&D.

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Tue, 02 Sep 2014 16:00:00 +0200 IR Thematic Conference Call on Alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call for the financial community focusing on alirocumab during the European Society of Cardiology Congress in Barcelona.

http://en.sanofi.com/investors/events/corporate/2014/2014-09-02_IR_Seminar_Alirocumab.aspx
Fri, 01 Aug 2014 15:00:00 +0200 Publication of the Half-year financial report 2014 http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx Thu, 31 Jul 2014 07:30:00 +0200 Second quarter results 2014

Second quarter results for 2014 were reviewed by management during a conference call with the financial community.

http://en.sanofi.com/investors/events/corporate/2014/2014-07-31_Results_Q2-2014.aspx
Thu, 26 Jun 2014 10:00:00 +0200 Letter to Shareholders - June 2014

This new issue of the Letter focuses on Q1 2014 results, our dengue vaccine candidate, Genzyme's options for multiple sclerosis patients and the AGM 2014.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Mon, 16 Jun 2014 17:30:00 +0200 IR Thematic Conference Call on Diabetes

At 6:00 pm CET (9:00 PDT) Sanofi will host an IR Thematic Conference Call for the financial community in connection with the American Diabetes Association's Scientific Sessions.

http://en.sanofi.com/investors/events/corporate/2014/2014-06-16_IR_Seminar_Diabetes.aspx
Wed, 07 May 2014 16:00:00 +0200 Deutsche Bank Healthcare Conference, Boston, U.S.

Presentation by David Meeker, Executive Vice President, Genzyme

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Mon, 05 May 2014 14:00:00 +0200 Shareholder Handbook 2014 edition http://en.sanofi.com/investors/indiv_shareholders/publications/handbook/handbook.aspx Mon, 05 May 2014 14:00:00 +0200 Publication of the Annual Review 2013 and the CSR Report 2013

 

http://en.sanofi.com/investors/news/news.aspx
Mon, 05 May 2014 14:30:00 +0200 Shareholders’ General Meeting, Paris, France

The Sanofi Combined General Meeting was held on May 5, 2014 at the Palais des Congrès in Paris, France.

http://en.sanofi.com/investors/events/general_meetings/2014_meeting/2014_meeting.aspx
Tue, 29 Apr 2014 07:30:00 +0200 First quarter results 2014

First quarter results for 2014 were reviewed by management during a conference call with the financial community.

http://en.sanofi.com/investors/events/corporate/2014/2014-04-29_Results_Q1-2014.aspx
Fri, 11 Apr 2014 10:00:00 +0200 Letter to Shareholders - March 2014

This new issue of the Letter focuses on full-year results of 2013, our late-stage development pipeline and the agenda of the AGM 2014.

http://en.sanofi.com/investors/indiv_shareholders/publications/letters/letters.aspx
Mon, 31 Mar 2014 11:00:00 +0200 IR Thematic Conference Call on Alirocumab

At 3:00 pm CET (9:00 ET) Sanofi and Regeneron will host an IR Thematic Conference Call for the financial community focusing on alirocumab during the upcoming American College of Cardiology Annual Meeting.

http://en.sanofi.com/investors/events/corporate/2014/2014-03-31_IR_Seminar_Alirocumab.aspx
Tue, 25 Mar 2014 11:00:00 +0100 Exane BNP Paribas Healthcare Conference, Paris, France

Presentation by Fabrice Baschiera, General Manager, Commercial Operations, Greater China

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Wed, 12 Mar 2014 17:00:00 +0100 Barclays Global Healthcare Conference, Miami, U.S.

Presentation by Paul Chew, Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Fri, 07 Mar 2014 18:00:00 +0100 Publication of the Annual Report on Form 20-F 2013 and Document de Référence 2013 http://en.sanofi.com/investors/news/financial_publications/financial_publications.aspx Mon, 03 Mar 2014 17:00:00 +0100 Cowen Annual Healthcare Conference, Boston, U.S.

Presentation by Gary J. Nabel, Senior Vice President, Chief Scientific Officer

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
Tue, 14 Jan 2014 17:00:00 +0100 JPMorgan Health Care Conference, San Francisco, U.S.

Presentation by Christopher A. Viehbacher, CEO

http://en.sanofi.com/investors/events/other_events/2014/2014.aspx
5 © Sanofi 2004-2017